133.99
Neurocrine Biosciences Inc (NBIX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
20.07%
687.50
|
572.60 | 622.10 | 590.20 | 515.30 |
Cost Of Revenue |
22.83%
11.30
|
9.20 | 8.00 | 9.20 | 7.50 |
Gross Profit |
20.02%
676.20
|
563.40 | 614.10 | 581.00 | 507.80 |
|
1.70%
530.60
|
539.80 | 430.30 | 435.60 | 408.50 |
Benefits Costs and Expenses |
5.36%
528.00
|
557.90 | 431.80 | 491.60 | 480.80 |
Costs And Expenses |
1.29%
541.90
|
549.00 | 438.30 | 444.80 | 416.00 |
Operating Income/Loss |
516.95%
145.60
|
23.60 | 183.80 | 145.40 | 99.30 |
Nonoperating Income/Loss |
256.18%
13.90
|
-8.90 | 6.50 | -46.80 | -64.80 |
Income/Loss From Continuing Operations Before Tax |
985.03%
159.50
|
14.70 | 190.30 | 98.60 | 34.50 |
Income Tax Expense/Benefit |
664.71%
52.00
|
6.80 | 60.50 | 33.60 | -8.90 |
Income/Loss From Continuing Operations After Tax |
1,261%
107.50
|
7.90 | 129.80 | 65.00 | 43.40 |
|
1,261%
107.50
|
7.90 | 129.80 | 65.00 | 43.40 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.70%
99.00
|
99.70 | 101.10 | 100.80 | 99.80 |
Diluted Average Shares |
1.46%
101.00
|
102.50 | 104.30 | 103.90 | 103.60 |
Basic Earnings Per Share |
1,262%
1.09
|
0.08 | 1.28 | 0.64 | 0.43 |
Diluted Earnings Per Share |
1,225%
1.06
|
0.08 | 1.24 | 0.63 | 0.42 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):